methylprednisolone hemisuccinate has been researched along with calpain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caiozzo, V; Gardner, VO | 1 |
| Ahmed, EA; Ahmed, MF; Al-Abbadi, HA; Hashem, MA; Helal, IE; Maaty, AI; Mahmoud, YK; Metwally, E | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and calpain
| Article | Year |
|---|---|
Medical management of spinal cord injury.
Topics: Calpain; Humans; Ischemia; Methylprednisolone Hemisuccinate; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Spinal Cord Injuries | 1991 |
Selective Calpain Inhibition Improves Functional and Histopathological Outcomes in a Canine Spinal Cord Injury Model.
Topics: Acrylates; Animals; Anti-Inflammatory Agents; Calcium-Binding Proteins; Calpain; Dogs; Methylprednisolone Hemisuccinate; Spinal Cord; Spinal Cord Injuries | 2022 |